Given that ~90% of cancer research is funded in the United States [0], that might work for established therapies but anything on the cutting edge might be hard to get?
According to this article from MGH, cutting edge immunotherapies cost ~$1M per patient: http://protomag.com/articles/solid-tumor-barrier
And this one demonstrates the delays in their availability in Europe. Sucks big time for the people currently needing treatment: https://www.bloomberg.com/news/articles/2018-09-12/novartis-...
[0] #62 Peter Attia M.D. podcast with Keith Flaherty MGH
Given that ~90% of cancer research is funded in the United States [0], that might work for established therapies but anything on the cutting edge might be hard to get?
According to this article from MGH, cutting edge immunotherapies cost ~$1M per patient: http://protomag.com/articles/solid-tumor-barrier
And this one demonstrates the delays in their availability in Europe. Sucks big time for the people currently needing treatment: https://www.bloomberg.com/news/articles/2018-09-12/novartis-...
[0] #62 Peter Attia M.D. podcast with Keith Flaherty MGH